Digoxin Injection
Product Images NDC 51662-1217

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 51662-1217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage 1 (Dosage And Admin Tabel 1)

A data table showing the total IV loading dose in mcg/kg for Digoxin injection by age group. It specifies the dosing for adults and pediatric patients over 10 years old as 8-12 mcg/kg, with instructions to administer half the total loading dose initially, then one quarter of the dose every 6-8 hours twice.*

FDA Label Image

Dosage 2 (Dosage And Admin Tabel 2)

A data table showing total intravenous maintenance dose of Digoxin for adults and pediatric patients over 10 years old, with dosage given once daily ranging from 2.4 to 3.6 mcg/kg/day.*

FDA Label Image

Dosage 3 (Dosage And Admin Tabel 3)

A data table showing corrected values of creatinine clearance (mL/min) across different lean body weights (40 to 100 kg) and the corresponding number of days before steady state is achieved for Digoxin injection. The table includes values for creatinine clearance ranging from 10 to 100 mL/min with days to steady state decreasing as clearance increases.*

FDA Label Image

Dosage 4 (Dosage And Admin Tabel 4)

A data table comparing absolute bioavailability and equivalent doses in micrograms (mcg) for Digoxin tablets and Digoxin intravenous injection. The tablets show 60-80% bioavailability with doses of 62.5, 125, 250, and 500 mcg; the intravenous injection shows 100% bioavailability with doses of 50, 100, 200, and 400 mcg.*

FDA Label Image

Interactions 1 (Drug Interaction Tabel 1)

A data table titled 'Digoxin concentrations increased greater than 50%' and 'Digoxin concentrations increased less than 50%' showing serum concentration increases, AUC increases, and clinical recommendations for various drugs interacting with digoxin. Drugs listed include Quinidine, Ritonavir, Amiodarone, Propafenone, Quinine, Spironolactone, and Verapamil, with associated values and dosing guidance for managing digoxin levels.*

FDA Label Image

Interactions 2 (Drug Interactions Tabel 2)

A data table listing drugs and substances that affect renal function and interact with digoxin, including categories like antiarrhythmics, parathyroid hormone analog, thyroid supplement, sympathomimetics, neuromuscular blocking agents, supplements, beta-adrenergic blockers, calcium channel blockers, and ivabradine, with details on their associated risks and effects when used with digoxin.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of digoxin, showing its steroid nucleus and attached sugar moieties. The structure highlights hydroxyl, methyl, and oxygen-containing functional groups characteristic of digoxin.*

FDA Label Image

Clinical (Clinical Pharmacology Tabel)

A data table comparing Digoxin formulations by their time to onset and peak effect. It shows Digoxin Tablets with onset of 0.5 to 2 hours and peak effect 2 to 6 hours, and Digoxin Injection/IV with onset of 5 to 30 minutes and peak effect 1 to 4 hours.*

FDA Label Image

Logo (Logo Patient Cons)

FDA Label Image

Ampule (1000180 0641 1410 31 Digoxin Ampule Label)

Label for Digoxin Injection, USP 500 mcg/2 mL (0.5 mg/2 mL or 250 mcg/mL) in a 2 mL ampul, from HF Acquisition Co LLC, DBA HealthFirst. The label indicates use for slow intravenous or deep intramuscular injection and includes the distributor as West-Ward. It shows the NDC 0641-1410-31 and space for lot and expiration data.*

FDA Label Image

Rfid Label (51662 1217 1 Rfid Label)

A rectangular white label displaying GS1 data matrix barcode and human-readable Global Trade Item Number (GTIN) and serial number information. The label includes text instructing to see the manufacturer's insert and states distribution by HF Acquisitions Co., LLC in Mukilteo, WA 98275. The label is from DIGOXIN injection product by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Label (51662 1217 3 Case Label)

Label for Digoxin Injection USP, 500 mcg/2 mL (equivalent to 0.5 mg/2 mL or 250 mcg/mL), in a 2 mL ampule. The label displays NDC 51662-1217-2, lot number 789210, and expiration date 2030-09-19. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

Label (51662 1217 2 Pouch)

Label for Digoxin Injection USP 0.5 mg/2 mL (250 mcg/mL) in 2 mL ampules, box of 25, manufactured by HF Acquisition Co LLC. The label shows the NDC 51662-1217 and lot number 789210 with an expiration date of 2030-09-19. It includes storage instructions and manufacturer location in Mukilteo, WA.*

FDA Label Image

Rfid Label (51662 1217 3 Rfid)

Label on a Digoxin injection package showing a barcode and human-readable text including NDC 00351662121733 and batch or lot number information. The label instructs to see the manufacturer's insert and lists the distributor as HF Acquisitions Co., LLC, Mukilteo, WA 98275.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.